Package 71335-9764-1
Brand: chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride and clidinium bromidePackage Facts
Identity
Package NDC
71335-9764-1
Digits Only
7133597641
Product NDC
71335-9764
Description
100 CAPSULE in 1 BOTTLE (71335-9764-1)
Marketing
Marketing Status
Brand
chlordiazepoxide hydrochloride and clidinium bromide
Generic
chlordiazepoxide hydrochloride and clidinium bromide
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "14333b2e-2e13-424d-819a-b08667725247", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["68d8dca6-697d-401e-acaf-01bfe4c4da17"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (71335-9764-1)", "package_ndc": "71335-9764-1", "marketing_start_date": "20230815"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "71335-9764_14333b2e-2e13-424d-819a-b08667725247", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "71335-9764", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA211421", "marketing_category": "ANDA", "marketing_start_date": "20200709", "listing_expiration_date": "20261231"}